24/7 Customer Support

+1 718 473 0872

Pharmaceutical Markets in the US

Solid Q on top and bottom Lines

  • January 2012
  • 23 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

  • Geographic Coverage

    United States  

    World  

  • Type of data

    Demand  

  • Price Objective Change 1
  • iQmethod SM - Bus Performance* 2
  • (US$ Millions) 2
  • iQmethod SM - Quality of Earnings* 2
  • Income Statement Data (Dec) (US$ Millions) 2
  • Free Cash Flow Data (Dec) (US$ Millions) 2
  • Balance Sheet Data (Dec) (US$ Millions) 2
  • Company Description 2
  • Stock Data 2
  • Quarterly Earnings Estimates 2
  • Investment Thesis 2
  • Teva Pharmaceutical Industries Annual Earnings Model 4
  • Teva Pharmaceutical Industries Quarterly Revenue Model (continued) 7
  • Teva Pharmaceutical Industries Annual Revenue Model 9
  • Teva Pharmaceutical Industries Annual Revenue Model (continued) 10
  • Price objective basis & risk 19
  • Link to Definitions 19
  • Analyst Certification 19
  • BofA Merrill Lynch ticker Bloomberg symbol Analyst 19
  • iQmethod SM Measures Definitions 20
  • Business Performance 20
  • Quality of Earnings 20
  • Valuation Toolkit 20
  • Numerator 20
  • Denominator 20
  • Investment Rating Distribution: Global Group (as of 01 Jan 2012) Coverage
  • Universe 21
  • Count 21
  • Percent 21
  • Inv. Banking Relationships* 21
  • Count 21
  • Percent 21
  • FUNDAMENTAL EQUITY OPINION KEY: Opinions include a Volatility Risk Rating, an
  • Investment Rating and an Income Rating. VOLATILITY RISK 21
  • Count 21
  • Investment Rating Distribution: Health Care Group (as of 01 Jan 2012) Coverage
  • Universe 21
  • Merrill Lynch representative or Merrill Lynch Global Wealth Management financial
  • advisor if they have questions concerning this report. 22
  • Information relating to Non-US affiliates of BofA Merrill Lynch and Distribution
  • of Affiliate Research Reports 22
  • General Investment Related Disclosures 22
  • Other Important Disclosures 22
  • Copyright and General Information regarding Research Reports 23
  • Price Objective Change 1
  • Teva Pharmaceutical Industries Quarterly Earnings Model 3
  • Teva Pharmaceutical Industries Quarterly Revenue Model 5
  • Teva Pharmaceutical Industries Quarterly Revenue Model (continued) 6
  • Teva Pharmaceutical Industries Copaxone Model 13
  • Teva Pharmaceutical Industries Provigil & Nuvigil Sales Model 16
  • Teva Pharmaceutical Industries Actiq & Fentora Sales Model 17
  • Teva Pharmaceutical Industries US Amrix Sales Model 18
  • Important Disclosures 21

Refine your search results

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.